Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Morris Ling, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. F32AI108125 (LING, MORRIS) Jul 1, 2014 - Jun 30, 2015
    NIH
    CCR8 positive T cells and chronic allergic inflammation in asthma
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Barmettler S, DiGiacomo DV, Yang NJ, Lam T, Naranbhai V, Dighe AS, Burke KE, Blumenthal KG, Ling M, Hesterberg PE, Saff RR, MacLean J, Ofoman O, Berrios C, St Denis KJ, Lam EC, Gregory D, Iafrate AJ, Poznansky M, Lee H, Balazs A, Pillai S, Farmer JR. Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency. J Allergy Clin Immunol Pract. 2022 06; 10(6):1622-1634.e4. PMID: 35381395; PMCID: PMC8976568.
    Citations: 2     Fields:    Translation:HumansCells
  2. Ling M, Murali M. Antinuclear Antibody Tests. Clin Lab Med. 2019 12; 39(4):513-524. PMID: 31668266.
    Citations: 1     Fields:    Translation:Humans
  3. Ling M, Murali M. Analysis of the Complement System in the Clinical Immunology Laboratory. Clin Lab Med. 2019 12; 39(4):579-590. PMID: 31668271.
    Citations: 17     Fields:    Translation:Humans
  4. Cho JL, Ling MF, Adams DC, Faustino L, Islam SA, Afshar R, Griffith JW, Harris RS, Ng A, Radicioni G, Ford AA, Han AK, Xavier R, Kwok WW, Boucher R, Moon JJ, Hamilos DL, Kesimer M, Suter MJ, Medoff BD, Luster AD. Allergic asthma is distinguished by sensitivity of allergen-specific CD4+ T cells and airway structural cells to type 2 inflammation. Sci Transl Med. 2016 10 05; 8(359):359ra132. PMID: 27708065; PMCID: PMC5399547.
    Citations: 17     Fields:    Translation:HumansCells
  5. Ling MF, Luster AD. Allergen-Specific CD4(+) T Cells in Human Asthma. Ann Am Thorac Soc. 2016 Mar; 13 Suppl 1:S25-30. PMID: 27027948.
    Citations: 13     Fields:    Translation:HumansCells
  6. Okamoto R, Mandal K, Ling M, Luster AD, Kajihara Y, Kent SB. Total chemical synthesis and biological activities of glycosylated and non-glycosylated forms of the chemokines CCL1 and Ser-CCL1. Angew Chem Int Ed Engl. 2014 May 12; 53(20):5188-93. PMID: 24644239.
    Citations: 5     Fields:    Translation:Cells
  7. Wong JT, Ling M, Patil S, Banerji A, Long A. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization. J Allergy Clin Immunol Pract. 2014 Jan-Feb; 2(1):40-5. PMID: 24565767.
    Citations: 14     Fields:    Translation:Humans
  8. Islam SA, Ling MF, Leung J, Shreffler WG, Luster AD. Identification of human CCR8 as a CCL18 receptor. J Exp Med. 2013 Sep 23; 210(10):1889-98. PMID: 23999500.
    Citations: 69     Fields:    Translation:HumansAnimalsCells
  9. Patil SU, Long AA, Ling M, Wilson MT, Hesterberg P, Wong JT, Banerji A. A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions. J Allergy Clin Immunol. 2012 Feb; 129(2):443-7. PMID: 22099941.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  10. Ling MF, Luster AD. Novel approach to inhibiting chemokine function. EMBO Mol Med. 2011 Sep; 3(9):510-2. PMID: 21882341.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  11. Ling M, Hamilos DL. Are we closer to understanding the pathophysiology of chronic rhinosinusitis? Clin Exp Allergy. 2011 Feb; 41(2):144-6. PMID: 21231974.
    Citations:    Fields:    Translation:Humans
  12. Ling M, Long AA. Pet dander and difficult-to-control asthma: Therapeutic options. Allergy Asthma Proc. 2010 Sep-Oct; 31(5):385-91. PMID: 20929605.
    Citations: 11     Fields:    Translation:HumansAnimals
  13. Roden RB, Ling M, Wu TC. Vaccination to prevent and treat cervical cancer. Hum Pathol. 2004 Aug; 35(8):971-82. PMID: 15297964.
    Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
  14. Cheng WF, Hung CF, Lin KY, Ling M, Juang J, He L, Lin CT, Wu TC. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination. Gene Ther. 2003 Aug; 10(16):1311-20. PMID: 12883527.
    Citations: 18     Fields:    Translation:AnimalsCells
  15. Kim TW, Hung CF, Ling M, Juang J, He L, Hardwick JM, Kumar S, Wu TC. Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. J Clin Invest. 2003 Jul; 112(1):109-17. PMID: 12840065; PMCID: PMC162284.
    Citations: 62     Fields:    Translation:AnimalsCellsPHPublic Health
  16. Hung CF, Cheng WF, He L, Ling M, Juang J, Lin CT, Wu TC. Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes. Cancer Res. 2003 May 15; 63(10):2393-8. PMID: 12750257.
    Citations: 25     Fields:    Translation:AnimalsCells
  17. Moniz M, Ling M, Hung CF, Wu TC. HPV DNA vaccines. Front Biosci. 2003 Jan 01; 8:d55-68. PMID: 12456324.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  18. Cheng WF, Hung CF, Pai SI, Hsu KF, He L, Ling M, Wu TC. Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects. J Biomed Sci. 2002 Nov-Dec; 9(6 Pt 2):675-87. PMID: 12432234.
    Citations: 7     Fields:    Translation:AnimalsCellsPHPublic Health
  19. Hung CF, He L, Juang J, Lin TJ, Ling M, Wu TC. Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen. J Virol. 2002 Mar; 76(6):2676-82. PMID: 11861834; PMCID: PMC135982.
    Citations: 19     Fields:    Translation:AnimalsCells
  20. Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Polo JM, Slater LA, Ling M, Wu TC. Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion. Hum Gene Ther. 2002 Mar 01; 13(4):553-68. PMID: 11874633.
    Citations: 37     Fields:    Translation:AnimalsCells
  21. Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Ling M, Wu TC. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest. 2001 Sep; 108(5):669-78. PMID: 11544272; PMCID: PMC209378.
    Citations: 110     Fields:    Translation:AnimalsCells
  22. Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Rice CM, Ling M, Wu TC. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene. J Immunol. 2001 May 15; 166(10):6218-26. PMID: 11342644.
    Citations: 12     Fields:    Translation:HumansAnimalsCells
  23. Hung CF, Cheng WF, Hsu KF, Chai CY, He L, Ling M, Wu TC. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res. 2001 May 01; 61(9):3698-703. PMID: 11325841.
    Citations: 51     Fields:    Translation:HumansAnimalsCells
  24. Hung CF, Cheng WF, Chai CY, Hsu KF, He L, Ling M, Wu TC. Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J Immunol. 2001 May 01; 166(9):5733-40. PMID: 11313416.
    Citations: 30     Fields:    Translation:HumansAnimalsCells
  25. Cheng WF, Hung CH, Chai CY, Hsu KF, He L, Ling M, Wu TC. Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen. J Virol. 2001 Mar; 75(5):2368-76. PMID: 11160740; PMCID: PMC114820.
    Citations: 17     Fields:    Translation:AnimalsCellsPHPublic Health
  26. Hsu KF, Hung CF, Cheng WF, He L, Slater LA, Ling M, Wu TC. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther. 2001 Mar; 8(5):376-83. PMID: 11313814.
    Citations: 26     Fields:    Translation:HumansAnimalsCellsPHPublic Health
  27. Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Ling M, Slater LA, Roden RB, Wu TC. Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments. Hum Gene Ther. 2001 Feb 10; 12(3):235-52. PMID: 11177561.
    Citations: 20     Fields:    Translation:HumansAnimalsCells
  28. Hung CF, Hsu KF, Cheng WF, Chai CY, He L, Ling M, Wu TC. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand. Cancer Res. 2001 Feb 01; 61(3):1080-8. PMID: 11221836.
    Citations: 31     Fields:    Translation:HumansAnimalsCells
  29. Chen CH, Wang TL, Ji H, Hung CF, Pardoll DM, Cheng WF, Ling M, Wu TC. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene. Gene Ther. 2001 Jan; 8(2):128-38. PMID: 11313782.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  30. Ling M, Kanayama M, Roden R, Wu TC. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers. J Biomed Sci. 2000 Sep-Oct; 7(5):341-56. PMID: 10971133.
    Citations: 8     Fields:    Translation:HumansCells
  31. Wang TL, Ling M, Shih IM, Pham T, Pai SI, Lu Z, Kurman RJ, Pardoll DM, Wu TC. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. Gene Ther. 2000 May; 7(9):726-33. PMID: 10822298.
    Citations: 44     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Ling's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (188)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.